1
                                                                    EXHIBIT 14
 
[TALBERT LOGO]
 
3540 Howard Way
Costa Mesa, CA 92626
 
August 20, 1997
 
TO THE STOCKHOLDERS OF TALBERT MEDICAL MANAGEMENT HOLDINGS CORPORATION
 
Dear Stockholder:
 
I am pleased to report that on August 14, 1997, Talbert Medical Management
Holdings Corporation ("Talbert") entered into a merger agreement with
MedPartners, Inc., a Delaware corporation ("MedPartners"), and its wholly-owned
subsidiary, Talmed Merger Corporation, a Delaware corporation (the
"Subsidiary"), that provides for the acquisition of all of the Common Stock of
Talbert by the Subsidiary at a price of $63.00 per share, net to the seller.
Under the terms of the proposed transaction, the Subsidiary has commenced a
tender offer for all outstanding shares of Talbert Common Stock (together with
their associated rights) at $63.00 per share. The tender offer is currently
scheduled to expire at 12:00 midnight (New York City time) on September 19,
1997.
 
Following the successful completion of the tender offer, upon approval by
stockholder vote, if required, the Subsidiary will be merged with and into
Talbert, and all shares not purchased in the tender offer will be converted in
the right to receive $63.00 per share in cash, net to seller, without interest.
 
YOUR BOARD OF DIRECTORS HAS, BY A UNANIMOUS VOTE OF THE DIRECTORS PRESENT,
APPROVED THE OFFER AND DETERMINED THAT THE TERMS OF THE OFFER AND THE RELATED
MERGER ARE FAIR TO, AND IN THE BEST INTERESTS OF, TALBERT STOCKHOLDERS.
ACCORDINGLY, THE BOARD OF DIRECTORS, BY A UNANIMOUS VOTE OF THE DIRECTORS
PRESENT, HAS RECOMMENDED THAT ALL TALBERT STOCKHOLDERS ACCEPT THE OFFER AND
TENDER THEIR SHARES.
 
In arriving at its recommendations, the Board of Directors gave careful
consideration to a number of factors. The factors considered by the Board of
Directors are more fully described in the Solicitation/Recommendation Statement
on Schedule 14D-9 (the "Schedule 14D-9") filed by Talbert with the Securities
and Exchange Commission and enclosed with this letter. We urge you to read
carefully the Schedule 14D-9 in its entirety so that you will be fully informed
as to the Board's recommendations.
 
Also accompanying this letter is a copy of the Offer to Purchase and related
materials, including a Letter of Transmittal for use in tendering shares. These
documents set forth the terms and conditions of the offer and provide
instructions as to how to tender your shares. We urge you to read each of the
enclosed materials carefully.
 
The management and directors of Talbert thank you for the support you have given
Talbert.
 
On behalf of the Board of Directors,
 
Sincerely,
 
/s/ JACK D. MASSIMINO
- - -----------------------------------
Jack D. Massimino
President and Chief Executive Officer